SAP30 and acute myeloid leukemia: (50) demonstrated that SAP30 can interact with UHRF1 to promote the activation of the MYC signaling pathway and abnormal self-renewal of leukemia-initiating cells, resulting in the occurrence and development of acute myeloid leukemia and poor prognosis.